BRPI0514206A - composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779 - Google Patents

composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779

Info

Publication number
BRPI0514206A
BRPI0514206A BRPI0514206-7A BRPI0514206A BRPI0514206A BR PI0514206 A BRPI0514206 A BR PI0514206A BR PI0514206 A BRPI0514206 A BR PI0514206A BR PI0514206 A BRPI0514206 A BR PI0514206A
Authority
BR
Brazil
Prior art keywords
cci
metabolites
methods
antibody
derivative
Prior art date
Application number
BRPI0514206-7A
Other languages
English (en)
Inventor
Ping Cai
Mark Ruppen
Russ Tsao
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0514206A publication Critical patent/BRPI0514206A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

COMPOSTO, ANTICORPO, KIT PARA MONITORAR A TERAPIA COM CCI-779, E, MéTODOS PARA DETECTAR METABóLITOS DE CCI-779, E PARA PRODUZIR UM METABóLITO SINTéTICO E UM DERIVADO DE CCI-779 Um método de gerar metabólitos sintéticos de CCI-779 é fornecido. Cinco novos derivados de CCI-779 são descritos, como o são métodos de usar estes derivados para detectar metabólitos de CCI-779 nas amostras.
BRPI0514206-7A 2004-08-10 2005-08-09 composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779 BRPI0514206A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60033704P 2004-08-10 2004-08-10
PCT/US2005/028108 WO2006038972A1 (en) 2004-08-10 2005-08-09 Cci-779 derivatives and methods of making same

Publications (1)

Publication Number Publication Date
BRPI0514206A true BRPI0514206A (pt) 2008-06-03

Family

ID=35159738

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514206-7A BRPI0514206A (pt) 2004-08-10 2005-08-09 composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779

Country Status (15)

Country Link
US (2) US7332601B2 (pt)
EP (1) EP1776370A1 (pt)
JP (1) JP2008517874A (pt)
CN (1) CN1993368A (pt)
AR (1) AR050452A1 (pt)
AU (1) AU2005292647A1 (pt)
BR (1) BRPI0514206A (pt)
CA (1) CA2577011A1 (pt)
GT (1) GT200500216A (pt)
MX (1) MX2007001676A (pt)
PA (1) PA8641501A1 (pt)
PE (1) PE20060642A1 (pt)
SV (1) SV2006002188A (pt)
TW (1) TW200616633A (pt)
WO (1) WO2006038972A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040693A1 (es) 2002-07-30 2005-04-13 Wyeth Corp Formulaciones parenterales
CA2577011A1 (en) * 2004-08-10 2006-04-13 Wyeth Cci-779 derivatives and methods of making same
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
CN101321770A (zh) * 2005-12-07 2008-12-10 惠氏公司 由雷帕霉素42-酯硼酸酯制备雷帕霉素42-酯的可放大方法
AR058282A1 (es) * 2005-12-07 2008-01-30 Wyeth Corp Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
US20140343128A1 (en) 2011-11-15 2014-11-20 Novartis Ag Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the Janus Kinase 2 - Signal Transducer and Activator of Transcription 5 pathway
US20150224190A1 (en) 2012-07-06 2015-08-13 Mohamed Bentires-Alj Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR interaction

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316885A (en) 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US5102876A (en) 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin
US5256790A (en) 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
US7279561B1 (en) * 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
ES2295093T3 (es) * 1993-04-23 2008-04-16 Wyeth Conjugados y anticuerpos de rapamicina.
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
TWI256395B (en) 1999-09-29 2006-06-11 Wyeth Corp Regioselective synthesis of rapamycin derivatives
JP4227649B2 (ja) 2003-08-07 2009-02-18 ワイス Ｃｃｉ−７７９の位置選択的合成
PL1735321T3 (pl) 2004-04-14 2009-04-30 Wyeth Corp Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
MXPA06011883A (es) 2004-04-14 2006-12-14 Wyeth Corp 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y sintesis enzimatica de dos etapas de 42-ester de prolina-rapamicina con acido 2,2-bis(hidroximetil)propionico y 42-ester de rapamicina con acido 2,2-bis(hidroximetil)propionic
JP4224115B2 (ja) 2004-04-14 2009-02-12 ワイス ラパマイシン４２−エステル誘導体の位置特異的合成
CN1946852A (zh) 2004-04-27 2007-04-11 惠氏公司 利用雷帕霉素特异性甲基化酶标记雷帕霉素
CA2577011A1 (en) * 2004-08-10 2006-04-13 Wyeth Cci-779 derivatives and methods of making same
WO2007056175A2 (en) 2005-11-04 2007-05-18 Wyeth 41-methoxy isotope labeled rapamycin 42-ester
CN101394867A (zh) 2006-03-07 2009-03-25 惠氏公司 大环内酯类免疫抑制剂的水溶性聚乙二醇结合物的制备方法

Also Published As

Publication number Publication date
GT200500216A (es) 2006-03-02
TW200616633A (en) 2006-06-01
EP1776370A1 (en) 2007-04-25
CN1993368A (zh) 2007-07-04
US20060036091A1 (en) 2006-02-16
AU2005292647A1 (en) 2006-04-13
JP2008517874A (ja) 2008-05-29
PA8641501A1 (es) 2006-09-08
US7332601B2 (en) 2008-02-19
SV2006002188A (es) 2006-03-15
WO2006038972A1 (en) 2006-04-13
PE20060642A1 (es) 2006-08-01
MX2007001676A (es) 2007-04-12
CA2577011A1 (en) 2006-04-13
AR050452A1 (es) 2006-10-25
US20100279364A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
BR112014007819A2 (pt) método para produzir hidrocarbonetos
BRPI0910375A2 (pt) "mecanismo e método para gerar sinais de saída de áudio usando metadados com base em objeto"
NO20084777L (no) Trinnvise sementeringsfremgangsmater som brukes ved samtidig boring og fôring
BRPI0914925A2 (pt) peptídeo cíclico, uso de um peptídeo, métodos para produzir um peptídeo cíclico e para diagnosticar uma doença ou condição, e, anticorpo
BR112012033358A2 (pt) método e aparelhos para detectar estruturas repetitivas em modelos de mesh 3d
BRPI0514206A (pt) composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779
EP4421490A3 (en) Methods for detecting dihydroxyvitamin d metabolites by mass spectrometry
BRPI0812267A2 (pt) Célula hospedeira fúngica filamentosa, método para produzir uma composição de proteína celulolítica, composição de proteína celulolítica, e, métodos para degradar ou converter um material, contendo celulose e para produzir um produto de fermentação
CL2012002539A1 (es) Sistema de control para el almacenamiento de productos frescos que comprende un medio analizador de gases con una unidad de control para determinar una composicion ajustada de gases para proteger a los productos de la degradacion fermentativa; uso de dicho sistema; y metodo de monitoreo y control.
NO20101257L (no) Stromlinje stromningssimulering av en modell som tilveiebringer en representasjon av frakturkorridorer
CO6351724A2 (es) Inhibidores de cmet
EP4502608A3 (en) Methods for detecting vitamin d metabolites by mass spectrometry
WO2009064789A3 (en) Methods for detecting and monitoring circulating cancer stem cells
CL2012000606A1 (es) Articulo para fumar que comprende gel carbonaceo seco, y filtro para un articulo para fumar.
WO2009108905A3 (en) Fluorescence polarization herg assay
BR112012024206A2 (pt) método e sistema para analisar uma amostra de sangue
NO20100338L (no) Fremgangsmate og anordning for hoyhastighets telemetri under boring
BRPI1015927A2 (pt) Kit e método para diagnosticar uma doença de tireoide e método para diagnosticar o hipotireoidismo, bem como célula e seu uso
MX2008003081A (es) Metodos para medir el contenido de humedad en la piel.
AR076113A1 (es) Metodo o sistema que usa biomarcadores para el seguimiento de un tratamiento
NO20093448L (no) Preparater av (-)-E-10-OH-NT og metoder for deres synteser og anvendelse
TW200628648A (en) Method and device for the threads division on a beamer
IL209243A (en) Administrable compositions, their use and methods for obtaining a diagnostic image
DE602004018982D1 (de) Schneidevorrichtung zum schneiden kontinuierlicher zigarettenstangen
EA201071025A1 (ru) Способ получения [фенилсульфанилфенил]пиперидинов

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.